MedPath

FDA Clears Philips' ROCC for Remote Radiology Operations

• Philips secures FDA 510(k) clearance for its Radiology Operations Command Center (ROCC), enhancing remote scanning and protocol management capabilities. • The ROCC system, compatible with various MR and CT systems, connects imaging experts with technologists across different locations. • A pilot study showed a 9% increase in scanning throughput with no exam recalls, demonstrating the system's efficiency. • The remote capabilities empower clinicians to deliver timely diagnoses and improve patient care by addressing the shortage of skilled technologists.

Philips has received FDA 510(k) clearance for its Radiology Operations Command Center (ROCC), enabling remote scanning and protocol management. This clearance allows expert radiologists to provide real-time assistance to technologists, addressing the growing challenge of a shortage of skilled professionals in the field. The system is already in use across North America and Europe.

Enhanced Remote Capabilities

The newly cleared remote scanning capabilities of ROCC allow experts to modify MR and CT scanner consoles from any location in real time. This feature is complemented by on-demand chat, voice, and video collaboration tools, ensuring privacy and security. The system is designed to work with any magnetic resonance (MR) or computerised tomography (CT) system, connecting imaging experts in a central command center with technologists at various locations within an organization.

Efficiency and Impact

A pilot study conducted at Imperial College Healthcare NHS Trust in London reported a 9% increase in scanning throughput and no exam recalls, highlighting the efficiency of ROCC. Shiv Gopalkrishnan, Business Leader Patient Care Informatics at Philips, stated that healthcare providers are increasingly challenged by a lack of skilled technologists to meet the demand for patient imaging exams, especially complex ones like cardiac MR. He added that the 510(k) clearance of ROCC's remote capabilities further empowers clinicians to deliver timely diagnoses and better care for more patients.

Upcoming Demonstration

Philips is set to demonstrate the ROCC at the upcoming Radiological Society of North America Annual Meeting in Chicago from December 1-4, 2024. The company will also unveil its next-generation BlueSeal 1.5T MRI system at the meeting.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

FDA Clears Roche's VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail for B-Cell Lymphoma Diagnosis

Roche's VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail receives FDA 510(k) clearance for in-situ hybridization testing.
The test aids pathologists in distinguishing B-cell malignancies from reactive responses, enabling quicker access to treatment.

SyntheticMR's SyMRI 15 Receives FDA 510(k) Clearance for Diagnostic Image Replacement

SyntheticMR's SyMRI 15 has received FDA 510(k) clearance, enabling its use for diagnostic image replacement of conventional MRI images.
The technology enhances MRI workflows by replacing conventional 3D imaging and providing tissue quantification.

Centerline Biomedical's IOPS Guidewire Handle Receives FDA 510(k) Clearance

Centerline Biomedical's IOPS Guidewire Handle, a second-generation device, has received FDA 510(k) clearance, enhancing its IOPS technology portfolio.
The IOPS Guidewire Handle, used with a sensorized guidewire and viewpoint catheter, supports real-time 3D navigation of vasculature.

Nanox's ARC Imaging System Receives FDA Clearance for Expanded Use

Nanox's ARC imaging system secures FDA 510(k) clearance for general use, including pulmonary, intra-abdominal, and paranasal sinus indications, expanding its market potential.
The Nanox.ARC system utilizes digital X-ray technology with cold cathode tomosynthesis, providing enhanced 3D visualization compared to traditional 2D X-rays.

MVITRO's ORTIV Receives FDA Clearance for Needle-Free Blood Sampling

MVITRO's ORTIV, a laser-based device for painless blood sampling and glucose monitoring, has secured FDA 510(k) clearance, marking a significant advancement in diabetes management.
ORTIV utilizes micro-lasers to minimize skin damage and eliminate infection risks, offering real-time glucose readings via a dedicated app, addressing the stress of traditional blood sampling.

Insightec's Exablate Prime Receives FDA Approval for Use with Philips MRI Systems

Insightec's Exablate Prime system has gained FDA approval and CE mark for integration with select Philips MRI systems, expanding access to non-invasive treatments.
The approval covers Philips 1.5T and 3.0T Ingenia systems, Ambition 1.5T, Elition 3.0T, and MR 7700 3.0T, enhancing treatment options for patients.

Polarean Imaging Receives FDA Clearance to Expand MRI Chest Coil Compatibility

Polarean Imaging secured FDA 510k clearance for its MRI chest coil to include GE Healthcare's 3 Tesla MRI scanners, enhancing Xenon-129 nuclei visualization.
The expanded clearance ensures Polarean's Xenon MRI technology is accessible to more institutions and clinicians across the U.S. for lung disease detection.

FDA Clears Philips Spectral 4DCT for Enhanced Precision in Radiation Oncology

The FDA has granted 510(k) clearance to Philips Spectral CT 7500 RT, a spectral 4DCT respiratory-gated imaging solution for radiation oncology.
Spectral CT 7500 RT enhances accuracy in cancer treatment planning, minimizing damage to healthy tissue and potential adverse effects.

FDA Clears Gentuity's HF-OCT Imaging System for Coronary Interventions

Gentuity receives FDA 510(k) clearance for its HF-OCT imaging system with the Vis-Rx micro-imaging catheter, enhancing coronary intervention procedures.
The system is the only intravascular imaging platform indicated for pre- and post- percutaneous coronary intervention (PCI) assessment, optimizing treatment plans.

Imricor Advances Towards Regulatory Approval in US and Europe for MRI-Guided Cardiac Ablation Technology

Imricor's FDA premarket approval review for its initial module was successfully completed ahead of schedule, marking a significant step toward US approval.
In Europe, the Vision-MR Ablation Catheter 2.0 is awaiting final certification after a positive audit, aligning with the stringent Medical Device Regulations (MDR).

Reference News

[1]
FDA grants 510(k) clearance to Philips ROCC capabilities - Yahoo Finance
finance.yahoo.com · Nov 25, 2024

Philips received FDA 510(k) clearance for remote scanning and protocol management on Radiology Operations Command Center...

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy